Lupin Divests U.S. Commercial Women's Health Specialty Business To Evofem Biosciences
(RTTNews) - Pharma major Lupin Ltd. announced Monday that it has divested its U.S. Commercial Women's Health Specialty Business to Evofem Biosciences, Inc. (EVFM), a U.S. biopharmaceutical company focused exclusively on Women's Health.
Lupin's U.S. Commercial Women's Health Specialty Business is primarily focused on commercializing SOLOSEC (secnidazole) 2g oral granules.
This FDA-approved single-dose antimicrobial agent provides a complete course of therapy for the treatment of bacterial vaginosis (BV) and trichomoniasis, two common sexual health infections.
read more
Evofem Biosciences Names Albert Altro As Interim CFO
Evofem Biosciences, Inc. (EVFM) announced Thursday the appointment of Albert Altro as Interim Chief Financial Officer of the Company. He replaces Jay File, who is leaving the Company to explore other opportunities.
RTTNews
|
692日前
Evofem Biosciences Says Vaginal Contraceptive Gel Phexxi Approved In Nigeria
Evofem Biosciences, Inc. (EVFM) announced Thursday that its hormone-free contraceptive vaginal gel Phexxi has been approved by the Nigerian Regulatory Agency NAFDAC (National Agency for Food and Drug Administration and Control). This is the first regulatory approval outside the U.S.
RTTNews
|
846日前
Evofem Inks Deal With Pharmacy Benefit Managers In The U.S. For Access To Phexxi
Evofem Biosciences, Inc. (EVFM) announced Tuesday it has reached an agreement with one of the nation's largest pharmacy benefit managers (PBMs) to ensure most women covered by this plan can fill their Phexxi prescriptions for pregnancy prevention, without restrictions such as prior authorization or step therapy. Phexxi is an on-demand method of birth control used to prevent pregnancy.
RTTNews
|
946日前
Fed Leaves Interest Rates Unchanged After Three Straight Cuts
After cutting interest rates for three straight meetings, the Federal Reserve on Wednesday announced its widely expected decision to leave interest rates unchanged following its first monetary policy meeting of 2025. The Fed said it decided to maintain the target range for the federal funds rate at 4.25 to 4.50 percent in support of its dual goals.
RTTNews
|
5時17分前
Swiss Market Ends On Firm Note
Swiss stocks turned in a fine performance on Wednesday, as investors indulged in some strong buying at several counters, focusing on earnings and other corporate news, while awaiting the monetary policy announcement from the Federal Reserve later in the day.
Data showing an improvement in Swiss investor sentiment supported the market.
RTTNews
|
5時47分前
Canadian Dollar Weakens As BoC Cuts Rates
The Canadian dollar declined against its major counterparts in the New York session on Wednesday, as the Bank of Canada lowered interest rates by a quarter point, noting consumer price inflation remains close to 2 percent and the economy is in excess supply.
RTTNews
|
6時7分前
European Stocks Close Mostly Higher
European stocks closed mostly higher on Wednesday as investors focused on corporate earnings news and looked ahead to policy announcements from the Federal Reserve and the European Central Bank.
RTTNews
|
6時7分前
Canadian Market Modestly Higher After BoC Delivers Another Rate Cut
Canadian stocks are turning in a mixed performance in cautious trade on Wednesday with investors digesting the Bank of Canada's interest rate decision and awaiting the monetary policy announcement from the Federal Reserve.
RTTNews
|
6時49分前
